Join
Live feed
·
PRReleasevia Quantisnow
Neurocrine Biosciences Inc. logo
Soleno Therapeutics Inc. logo

Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

ByQuantisnow·Wall Street's wire, on your screen.
NBIX· Neurocrine Biosciences Inc.SLNO· Soleno Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBIX (Neurocrine Biosciences Inc.), SLNO (Soleno Therapeutics Inc.) and more on Quantisnow.